Imagine cancer treatment that targets only the tumour. No large incisions. No radiation damaging healthy tissue. No long recovery. Just tiny, biodegradable robots, smaller than a single human hair, navigating through your body and doing the job with surgical precision.
That future is getting closer.
Researchers at Michigan State University, working with collaborators from Henry Ford Health and Arizona State University, have unveiled a breakthrough microrobot called **TriMag** — and it could change how we treat cancer, perform brain surgery, and deliver drugs inside the human body.
What makes TriMag different from previous microrobot designs isn't just its size. It's what it can *do*.
**Three powers in one device**
Most microrobots can do one thing. TriMag does three — simultaneously:
1. **Navigate with precision.** Magnets positioned outside the patient's body guide TriMag through tissue and organs, steering it like a tiny swimmer to its exact target.
2. **See in real time.** Magnetic particle imaging gives doctors a live, three-dimensional map of where the robot is — deep inside tissue, with no radiation and no interference from surrounding organs or bones.
3. **Destroy tumours with heat.** Once on target, TriMag generates localised heat to kill cancer cells — without touching healthy tissue nearby. It's targeted enough to destroy a tumour while leaving the surrounding organ unharmed.
'Now, with advanced microrobotic design and imaging tools, we can reliably build, track and activate microrobots deep inside the human body,' said lead researcher **Jinxing Li**, a Red Cedar Distinguished Assistant Professor at MSU's College of Engineering. 'Because the TriMag design is so versatile, it opens the door to treatments that were not possible before.'
**Inspired by nature**
The design is bio-inspired — its shape and movement mimic sperm cells, allowing it to swim through biological fluids efficiently. The robots are 3D-printed and biodegradable: they deliver their purpose, then the body breaks them down. No retrieval. No leftovers.
TriMag can be injected, swallowed, or applied topically depending on the procedure — and the same basic design could theoretically be adapted for different conditions, from cancer to eye disease to neurological disorders.
**Still early — but genuinely exciting**
TriMag is in early pre-clinical studies. It isn't ready for patients yet, and there's meaningful scientific work still to be done. But researchers describe the current milestone as a foundational proof of concept — evidence that three critical capabilities can be combined in a single microscopic device and reliably controlled inside a living body.
The findings were published in the journal *Advanced Materials* in March 2026.
For the millions of patients every year who go through cancer treatment — chemotherapy, radiation, invasive surgery — TriMag represents a possible future that is less painful, more precise, and kinder to the body. That future isn't here yet. But it's closer today than it was yesterday. 🤖
*Sources: Michigan State University · Henry Ford Health · Arizona State University · Advanced Materials (March 2026)*
